Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber

Condition:   Allergic Rhino-Conjunctivitis
Intervention:   Drug: AllerT
Sponsors:   Anergis;   Inflamax Research Incorporated
Recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.